XCEL-MT-OSTEO-ALPHA

N/A

Report date: 2023/01/12 15:47:43

Base Information

Drug NameXCEL-MT-OSTEO-ALPHA

Drug Alias NameXCEL-MT-OSTEO-ALPHA

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionOsteogenesis inducers

TargetsNot applicable

Therapy Area/IndicationsSpondylolisthesisFemur Head Necrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBanc De Sang I Teixits

China Registration ClassN/A

Develop Information

Active CompaniesBanc De Sang I Teixits

Inactive CompaniesN/A

Active IndicationsSpondylolisthesis

Inactive IndicationsFemur Head Necrosis

Other Information

ATC CodeN/A